SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : Tokyo Joe's Cafe / Anything goes -- Ignore unavailable to you. Want to Upgrade?


To: musicguy who wrote (20222)5/21/1998 1:03:00 PM
From: Fitz  Read Replies (2) | Respond to of 34592
 
HYALF

11:35 ET Hyal Pharmaceutical Corp (HYALF) 11/16 +3/16
(+38%): Company announced today that its lead product, Solarase,
has received approval from the Therapeutic Products Directorate
of Health Canada for marketing in Canada. The product is a topical
gel formulation to treat actinic keratosis (AK), precancerous skin
lesions caused by exposure to the sun. Volume 1.4 mln.